Does the Efficacy of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Differ According to the Type of EGFR Mutation in Non-Small Cell Lung Cancer?
Korean Journal of Internal Medicine - South Korea
doi 10.3904/kjim.2016.190
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 1, 2017
Authors
Publisher
Korean Association of Internal Medicine